Moderate Alcoholic Hepatitis

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Moderate alcoholic hepatitis (AH) is a frequent liver disease with an underestimated incidence.
• The natural history and prognosis of moderate AH require further elucidation.
• Existing prognostic scores for AH, such as MELD, are primarily validated for severe forms.

Purpose of the Study:

• To describe the natural history and outcomes of moderate alcoholic hepatitis.
• To evaluate the accuracy of prognostic scores in predicting mortality for moderate AH.
• To highlight the current treatment goals and therapeutic gaps in managing moderate AH.

Main Methods:

• Review of existing literature on the natural history and management of moderate alcoholic hepatitis.
• Analysis of prognostic scores, particularly MELD, for their applicability to moderate AH.
• Synthesis of data on mortality rates and complications associated with moderate AH.

Main Results:

• Short-term mortality for moderate AH ranges from 3% to 7%, with 1-year mortality between 13% and 20%.
• Liver-related complications, especially severe infections, are primary causes of mortality.
• The Model for End-Stage Liver Disease (MELD) score demonstrates accuracy in predicting short-term mortality in AH.

Conclusions:

• Moderate alcoholic hepatitis carries significant short- and medium-term mortality risks.
• Long-term alcohol abstinence remains the cornerstone of treatment for alcoholic hepatitis.
• There is an unmet need for novel therapeutic strategies for both moderate and severe forms of alcoholic hepatitis.